282 related articles for article (PubMed ID: 7720709)
1. RAR-specific agonist/antagonists which dissociate transactivation and AP1 transrepression inhibit anchorage-independent cell proliferation.
Chen JY; Penco S; Ostrowski J; Balaguer P; Pons M; Starrett JE; Reczek P; Chambon P; Gronemeyer H
EMBO J; 1995 Mar; 14(6):1187-97. PubMed ID: 7720709
[TBL] [Abstract][Full Text] [Related]
2. Induction of retinoid resistance in breast cancer cells by overexpression of cJun.
Yang L; Kim HT; Munoz-Medellin D; Reddy P; Brown PH
Cancer Res; 1997 Oct; 57(20):4652-61. PubMed ID: 9377582
[TBL] [Abstract][Full Text] [Related]
3. Separation of transactivation and AP1 antagonism functions of retinoic acid receptor alpha.
Nagpal S; Athanikar J; Chandraratna RA
J Biol Chem; 1995 Jan; 270(2):923-7. PubMed ID: 7822331
[TBL] [Abstract][Full Text] [Related]
4. Identification of a novel class of retinoic acid receptor beta-selective retinoid antagonists and their inhibitory effects on AP-1 activity and retinoic acid-induced apoptosis in human breast cancer cells.
Li Y; Hashimoto Y; Agadir A; Kagechika H; Zhang Xk
J Biol Chem; 1999 May; 274(22):15360-6. PubMed ID: 10336422
[TBL] [Abstract][Full Text] [Related]
5. Identification of the AP1-antagonism domain of retinoic acid receptors.
DiSepio D; Sutter M; Johnson AT; Chandraratna RA; Nagpal S
Mol Cell Biol Res Commun; 1999 Apr; 1(1):7-13. PubMed ID: 10329471
[TBL] [Abstract][Full Text] [Related]
6. Retinoids inhibit the actions of angiotensin II on vascular smooth muscle cells.
Haxsen V; Adam-Stitah S; Ritz E; Wagner J
Circ Res; 2001 Mar; 88(6):637-44. PubMed ID: 11282899
[TBL] [Abstract][Full Text] [Related]
7. Regulation of retinoid-induced differentiation in embryonal carcinoma PCC4.aza1R cells: effects of retinoid-receptor selective ligands.
Mills KJ; Vollberg TM; Nervi C; Grippo JF; Dawson MI; Jetten AM
Cell Growth Differ; 1996 Mar; 7(3):327-37. PubMed ID: 8838863
[TBL] [Abstract][Full Text] [Related]
8. Retinoic acid receptor antagonist BMS453 inhibits the growth of normal and malignant breast cells without activating RAR-dependent gene expression.
Yang L; Munoz-Medellin D; Kim HT; Ostrowski J; Reczek P; Brown PH
Breast Cancer Res Treat; 1999 Aug; 56(3):277-91. PubMed ID: 10573118
[TBL] [Abstract][Full Text] [Related]
9. Retinoic acid receptors inhibit AP1 activation by regulating extracellular signal-regulated kinase and CBP recruitment to an AP1-responsive promoter.
Benkoussa M; Brand C; Delmotte MH; Formstecher P; Lefebvre P
Mol Cell Biol; 2002 Jul; 22(13):4522-34. PubMed ID: 12052862
[TBL] [Abstract][Full Text] [Related]
10. Effects of novel RAR- and RXR-selective retinoids on myeloid leukemic proliferation and differentiation in vitro.
Shiohara M; Dawson MI; Hobbs PD; Sawai N; Higuchi T; Koike K; Komiyama A; Koeffler HP
Blood; 1999 Mar; 93(6):2057-66. PubMed ID: 10068679
[TBL] [Abstract][Full Text] [Related]
11. Increased retinoic acid responsiveness in lung carcinoma cells that are nonresponsive despite the presence of endogenous retinoic acid receptor (RAR) beta by expression of exogenous retinoid receptors retinoid X receptor alpha, RAR alpha, and RAR gamma.
Wan H; Hong WK; Lotan R
Cancer Res; 2001 Jan; 61(2):556-64. PubMed ID: 11212249
[TBL] [Abstract][Full Text] [Related]
12. Nicotine modulates the effects of retinoids on growth inhibition and RAR beta expression in lung cancer cells.
Chen GQ; Lin B; Dawson MI; Zhang XK
Int J Cancer; 2002 May; 99(2):171-8. PubMed ID: 11979430
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of tumor promoter-induced transformation by retinoids that transrepress AP-1 without transactivating retinoic acid response element.
Li JJ; Dong Z; Dawson MI; Colburn NH
Cancer Res; 1996 Feb; 56(3):483-9. PubMed ID: 8564958
[TBL] [Abstract][Full Text] [Related]
14. Unique anti-activator protein-1 activity of retinoic acid receptor beta.
Lin F; Xiao D; Kolluri SK; Zhang X
Cancer Res; 2000 Jun; 60(12):3271-80. PubMed ID: 10866321
[TBL] [Abstract][Full Text] [Related]
15. Regulation of retinoic acid-induced inhibition of AP-1 activity by orphan receptor chicken ovalbumin upstream promoter-transcription factor.
Lin F; Kolluri SK; Chen GQ; Zhang XK
J Biol Chem; 2002 Jun; 277(24):21414-22. PubMed ID: 11934895
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of trans-retinoic acid-resistant human breast cancer cell growth by retinoid X receptor-selective retinoids.
Wu Q; Dawson MI; Zheng Y; Hobbs PD; Agadir A; Jong L; Li Y; Liu R; Lin B; Zhang XK
Mol Cell Biol; 1997 Nov; 17(11):6598-608. PubMed ID: 9343423
[TBL] [Abstract][Full Text] [Related]
17. Modulation of retinoic acid receptor function alters the growth inhibitory response of oral SCC cells to retinoids.
Le Q; Dawson MI; Soprano DR; Soprano KJ
Oncogene; 2000 Mar; 19(11):1457-65. PubMed ID: 10723137
[TBL] [Abstract][Full Text] [Related]
18. Effects of novel retinoid X receptor-selective ligands on myeloid leukemia differentiation and proliferation in vitro.
Kizaki M; Dawson MI; Heyman R; Elster E; Morosetti R; Pakkala S; Chen DL; Ueno H; Chao W; Morikawa M; Ikeda Y; Heber D; Pfahl M; Koeffler HP
Blood; 1996 Mar; 87(5):1977-84. PubMed ID: 8634447
[TBL] [Abstract][Full Text] [Related]
19. Synergistic activation of retinoic acid (RA)-responsive genes and induction of embryonal carcinoma cell differentiation by an RA receptor alpha (RAR alpha)-, RAR beta-, or RAR gamma-selective ligand in combination with a retinoid X receptor-specific ligand.
Roy B; Taneja R; Chambon P
Mol Cell Biol; 1995 Dec; 15(12):6481-7. PubMed ID: 8524212
[TBL] [Abstract][Full Text] [Related]
20. Retinoids interfere with the AP1 signalling pathway in human breast cancer cells.
Dedieu S; Lefebvre P
Cell Signal; 2006 Jun; 18(6):889-98. PubMed ID: 16176868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
